Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
GlaxoSmithKline
Scientific Title
A Phase I/II Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies